Accelerate Diagnostics Inc.
AXDX
NSC
Sector: Healthcare
Industry: Diagnostics & Research
2.13
USD
0.18
(9.23%)
Optionable: Yes Market Cap: 132 M 90-day average vol: 1,070,943
Previous close: 1.95 Open: 1.95 Bid: 2.25 Ask: 2.25
52 week range
0.50 7.19
Last updated: Monday 8th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 13.99 |
Price per Book TTM ($) | -3.49 |
PE Ratio (TTM) | -1.30 |
Book Value per Share ($) | -0.61 |
5 Year PE Range | -22.2 , -7.5 |
Returns
7 Day Return | 51.06% | |
1 Month Return | 82.05% | |
3 Month Return | 180.67% | |
1 Year Return | -68.77% | |
3 Year Return | -87.18% | |
5 Year Return | -90.78% | |
YTD Return | -59.20% |
Risk
Custom Beta One Year | 1.22 |
Custom Beta Three Years | 1.24 |
Beneish M Score | -10.80 |
Altman Z Score | -10.54 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 78.27 |
14 Day SMA ($) | 1.52 |
14 Day EMA ($) | 1.58 |
Money Flow Index | 50.53 |
Average True Range | 0.18 |
50 Day SMA ($) | 1.10 |
200 Day SMA ($) | 2.72 |
ADX | 18.22 |
MACD | 0.21 |
Growth
Free Cash Flow QoQ Growth | 5.71% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -40.00% |
Revenue QoQ Growth | -11.52% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results
Yahoo Finance 2/24/2022
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Yahoo Finance 2/15/2022
Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates
Yahoo Finance 2/10/2022
Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time
Yahoo Finance 2/2/2022
What Is The Ownership Structure Like For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?
Yahoo Finance 1/31/2022
Ironwood Financial, llc Buys Accelerate Diagnostics Inc, Vanguard Total Stock Market ETF, ...
Yahoo Finance 1/28/2022
Accelerate Diagnostics slips 3% as prelim 4Q FY21 revenue expected to be below consensus
Seeking Alpha 1/13/2022
Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results
Yahoo Finance 1/13/2022
Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China Commercialization Efforts
Yahoo Finance 1/12/2022
Accelerate Diagnostics And T2 Biosystems: Financial Woes Set To Continue In 2022
Seeking Alpha 1/4/2022
Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022
Yahoo Finance 12/29/2021
The Independent Director of Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Jack Schuler, Just Bought 5.8% More Shares
Yahoo Finance 12/1/2021
Accelerate Diagnostics (NASDAQ:AXDX) investors are sitting on a loss of 78% if they invested five years ago
Yahoo Finance 11/27/2021
Accelerate Diagnostics rallies on insider buying
Seeking Alpha 11/24/2021
New Accelerate Pheno® System Multi-Center Study Published in Clinical Infectious Diseases
Yahoo Finance 11/22/2021
Accelerate Diagnostics gains after report on M&A interest
Seeking Alpha 11/12/2021
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q3 2021 Results - Earnings Call Transcript
Seeking Alpha 11/9/2021
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance 11/9/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 36.741
Financials
AXDX Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 18000 | 48000 | 122000 | 147000 | 246000 | 4 M | 6 M | 9 M | 11 M | 12 M |
| Cost of sales | -42999 | -439000 | -1 M | -2 M | -3 M | -2 M | 1 M | 3 M | 4 M | 9 M |
| Gross operating profit | 17999 | 48000 | 122000 | 147000 | 246000 | 3 M | 2 M | 4 M | 4 M | -381000 |
| Selling Gen & administrative expense | 1 M | 4 M | 11 M | 19 M | 37 M | 45 M | 55 M | 52 M | 47 M | 49 M |
| Research & development expense | 2 M | 11 M | 20 M | 27 M | 30 M | 22 M | 28 M | 25 M | 21 M | 22 M |
| Operating income | -3 M | -15 M | -31 M | -46 M | -67 M | -64 M | -80 M | -73 M | -64 M | -72 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -333000 | -11000 | -3000 | -19000 | -100000 | -259000 | -478000 | -138000 | 192000 | 9 M |
| Pre-tax Income (EBT) | -3 M | -15 M | -31 M | -45 M | -66 M | -64 M | -88 M | -84 M | -78 M | -78 M |
| Income taxes | 0 | 0 | 0 | 0 | 267000 | 493000 | 211000 | -111000 | 5000 | 45000 |
| Net income from total operations | -3 M | -15 M | -31 M | -45 M | -66 M | -64 M | -88 M | -84 M | -78 M | -78 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -3 M | -15 M | -31 M | -45 M | -66 M | -64 M | -88 M | -84 M | -78 M | -78 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -3 M | -15 M | -31 M | -45 M | -66 M | -64 M | -88 M | -84 M | -78 M | -78 M |
| Depreciation | 43000 | 439000 | 1 M | 2 M | 3 M | 3 M | 2 M | 2 M | 3 M | 3 M |
| Amortization | 38000 | 77000 | 71000 | 10000 | 11000 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -3 M | -15 M | -30 M | -44 M | -64 M | -61 M | -75 M | -68 M | -60 M | -60 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -0.13 | -0.41 | -0.71 | -1.01 | -1.29 | -1.18 | -1.62 | -1.55 | -1.4 | -1.26 |
| Diluted EPS total | -0.13 | -0.41 | -0.71 | -1.01 | -1.29 | -1.18 | -1.62 | -1.55 | -1.4 | -1.26 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!